The pathogenicity traits of avian pathogenic Escherichia coli O25-ST131 associated with avian colibacillosis in Georgia poultry and their genotypic and phenotypic overlap with other extraintestinal pathogenic E. coli.

Aims: To characterize Escherichia coli O25 ST131 (O25-ST131) isolated from Georgia poultry-a "global high-risk" clonal strain.

Methods And Results: Using multiplex PCR to detect target genes in 98 isolates of avian pathogenic E. coli (APEC) O25 recovered from avians diagnosed with colibacillosis (n = 87) and healthy chicks (n = 11) in Georgia, USA.

Longitudinal analysis of avian pathogenic Escherichia coli (APEC) serogroups and pathotypes from avian colibacillosis in Georgia: A continued investigation - year 2 analysis.

Avian pathogenic Escherichia coli (APEC) is a significant cause of worldwide morbidity, mortality, and production loss in the poultry industry. Here, we characterized 115 E. coli isolates from avian-diagnosed colibacillosis cases from Georgia, USA in 2022 as part of a year two follow on surveillance using both current and a newly developed serogrouping tool (Klao9-SeroPCR).

Longitudinal study of avian pathogenic (APEC) serogroups associated with disease in Georgia poultry using molecular serology and virulence gene analysis.

Several emerging APEC serogroups were observed in Georgia poultry populations.An association between APEC serogroups and bird type was observed.The prevalence of different APEC serogroups was influenced by season.

Efficacy and safety of adjustable balloons (Proact™) to treat male stress urinary incontinence after prostate surgery: Medium and long-term follow-up data of a national multicentric retrospective study.

Aims: Male stress urinary incontinence (SUI) represents a complication after radical prostatectomy or benign prostatic obstruction surgery. The artificial urinary sphincter is considered the standard treatment but interest on minimally invasive devices, such as adjustable balloons, has recently increased. Aim of this study is to evaluate the efficacy and safety of the ProACT system.

Efficacy and safety of artificial urinary sphincter (AUS): Results of a large multi-institutional cohort of patients with mid-term follow-up.

Aims: To assess efficacy and safety as well as predictive factors of dry rate and freedom from surgical revision in patients underwent AUS placement. The artificial urinary sphincter (AUS) is still considered the standard for the treatment of moderate to severe post-prostatectomy stress urinary incontinence (SUI). However, data reporting efficacy and safety from large series are lacking.